{
    "title": "China approves use of Pfizer's COVID drug Paxlovid",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10504669/China-approves-use-Pfizers-COVID-drug-Paxlovid.html",
    "date": "2022-02-12",
    "keywords": [
        "covid19",
        "pfizer",
        "treatment",
        "paxlovid",
        "pill",
        "china",
        "number",
        "approval",
        "drug",
        "risk",
        "illness",
        "onset",
        "course",
        "population",
        "regulator",
        "saturday",
        "disease",
        "country",
        "administration",
        "condition",
        "study",
        "authority",
        "milestone",
        "fight",
        "representative",
        "statement",
        "information",
        "procurement",
        "boost",
        "company",
        "capacity",
        "worldwide",
        "infection",
        "december",
        "trial",
        "chance",
        "hospitalisation",
        "death",
        "molnupiravir",
        "merck",
        "amp",
        "co",
        "year",
        "approach",
        "requirement",
        "roxanne",
        "liu",
        "john",
        "horwitz",
        "miyoung",
        "lincoln",
        "feast"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}